Q&A with FDA

U.S. Food and Drug Administration, Center for Drug Evaluation and Research
  • 5,0 (4)
  • MÉDECINE
  • TOUS LES MOIS
Q&A with FDA

"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.

  1. 4 DÉC.

    Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

    Q&A with FDA: Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray

    14 min

  2. 29 OCT.

    Understanding Drug Recalls with Dr. Ileana Elder

    In this episode of the Q&A with FDA podcast, learn about Understanding Drug Recalls with Dr. Ileana Elder in the Office of Compliance.

    25 min

  3. 27 SEPT.

    Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim

    In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.

    24 min

  4. 23 AOÛT

    Real-World Data and Evidence Generation with Dr. Hilary Marston

    In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to support the safety and effectiveness of drug products with Dr. Hilary Marston, FDA’s Chief Medical Officer.

    21 min

  5. 30 MAI

    The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad

    Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.

    24 min

  6. 3 MAI

    Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

    Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.

    12 min

  7. 18 MARS

    The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein

    The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein

    16 min

  8. 1 MARS

    Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng

    Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.

    15 min
Tout afficher (20)

Notes et avis

5
sur 5
4 notes

À propos

"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.

Informations

  • Création
    U.S. Food and Drug Administration, Center for Drug Evaluation and Research
  • Années d’activité
    2022 - 2024
  • Épisodes
    20
  • Classification
    Tous publics
  • Site web de l’émission
    Q&A with FDA

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada